Bengaluru — Canadian drugmaker Bausch Health said on Thursday that it will spin off its eye care unit, Bausch + Lomb, into a separate, publicly listed company, seven years after acquiring it for nearly $9bn.Bausch Health, previously known as Valeant Pharmaceuticals, has sought to get past a flurry of investigations into its accounting and pricing practices under its previous management.
Since its purchase in 2013, Bausch + Lomb has been a stable source of revenue for the company, especially after the accounting issues led to a steep fall in the share price of the one-time Wall Street darling, compounded by concerns over Bausch’s large debt pile.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dollar totters as stocks rise amid stimulus expectationsMarkets keep a firm eye on fiscal and monetary support packages
Source: BDliveSA - 🏆 12. / 63 Read more »
Yawning gaps in Covid-19 training for health-care staffSurvey reveals confusion about protective equipment required for different tasks
Source: BDliveSA - 🏆 12. / 63 Read more »
Hammerson proposes £551.7m rights issue as it eyes resuming dividend paymentsThe UK-focused landlord has been battling the effects of Brexit and Covid-19
Source: BDliveSA - 🏆 12. / 63 Read more »
WATCH: What helped RBPlat get back in the blackRBPlat CEO Steve Phiri talks to Business Day TV about the company’s performance
Source: BDliveSA - 🏆 12. / 63 Read more »
This is how BP plans to transform itself into a net-zero emissions company by 2050Overall, BP has gone further than any oil company but there are areas of concern
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: Channel24 - 🏆 48. / 51 Read more »